Nevertheless, this information is provided "as is" without any guarantee of accuracy, timeliness, completeness, or usefulness for any particular purpose
PubMed ID: 3122706 Ballard FJ et al
NT-501, a therapy involving encapsulated cell technology (ECT) intravitreal implants, delivers therapeutic agents directly into the vitreous humor for a duration of one to one-and-a-half years
Future research should prioritize rigorously designed prospective trials in thyroid-specific cohorts to validate these potential benefits
Gianotti, L., Alexander, J
This article examines the evidence on concurrent use, potential interactions, gastrointestinal considerations, and practical guidance for patients and healthcare professionals in the UK, aligned with MHRA and NICE recommendations